Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Doryx

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
  • 2018
  • Corpus ID: 53986624
=2703597; Carrier & Shadowen, supra note 10; Shepherd, supra note 7; Miller, supra note 2. 65 See, e.g., Allied Orthopedic… Expand
2017
2017
ABSTRACT The literature presently lacks a population pharmacokinetic analysis of doxycycline. This study aimed to develop a… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Review
2017
Review
2017
Several tensions exist between the Second Circuit’s decision in Namenda and the Third Circuit’s decision in Doryx, leaving… Expand
2016
2016
One of the most misunderstood and anticompetitive business behaviors in today’s economy is “product hopping,” which occurs when a… Expand
2016
2016
On Sept. 28, 2016, in Mylan Pharmaceuticals Inc. v. Warner Chilcott Public Limited Co. (Doryx),[1] the Third Circuit affirmed the… Expand
Review
2008
Review
2008
Tetracyclines have long been used to treat a wide variety of medical conditions, especially in the field of dermatology… Expand
2004
2004
SummaryIn a randomised, double-blind, 3-way cross-over trial, the incidence of nausea associated with 2 doxycycline 100 mg… Expand
  • table 1
1988
1988
  • R. S. Berger
  • Journal of clinical pharmacology
  • 1988
  • Corpus ID: 25983983
Ninety‐eight healthy subjects completed a double‐blind, placebo‐controlled, multiple‐dose cross‐over study to compare the… Expand